Baricitinib (CAS 1187594-09-7)
« Back to Anti-Rheumatism API
Baricitinib
CAS No. 1187594-09-7
巴瑞替尼
Chemical structure
| CAS No. | 1187594-09-7 |
|---|---|
| Synonyms | INCB 028050; LY 3009104; 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile |
| Category | Anti-Rheumatism API / Anti-Rheumatism |
| Assay / Purity | 99% |
| Molecular Formula | C16H17N7O2S |
| Molecular Weight | 371.4 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Off-white to white crystalline powder |
Application and positioning
Baricitinib is a JAK1/JAK2 inhibitor supplied as the free base. It is used in oral tablets for rheumatoid arthritis, atopic dermatitis and alopecia areata, with once-daily dosing. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Tofacitinib Citrate (CAS 540737-29-9)
- Upadacitinib (CAS 1310726-60-3)
- Methotrexate (CAS 59-05-2)
- 1-(Tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (CAS 1003846-21-6)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 1187594-09-7 · PubChem CID 44205240